US Broker Ratings

Masimo Corporation (MASI) Stock Analysis: Exploring a 38% Potential Upside Amid Healthcare Innovations

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, is capturing investor interest with a potential upside of 38.41%. Despite recent market challenges, Masimo’s innovative strides in medical..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 11.67% Upside in the Booming Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, is making waves within the medical devices industry. With a robust market capitalization of $11.94 billion, this U.S.-based..

Repligen Corporation (RGEN) Stock Analysis: Exploring the 13.85% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, continues to capture the attention of investors. With a market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring the Biotech’s Precision Oncology Potential

Revolution Medicines, Inc. (RVMD) is making waves in the biotechnology sector with its pioneering approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution Medicines is focused on..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unlocking a 46.77% Upside Potential in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the healthcare sector, particularly within the medical device industry, as a promising investment opportunity. With a market capitalization of $2.82 billion,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Evaluating the $10.46 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is carving out a niche in the healthcare sector with its focus on Traditional Chinese Medicine (TCM) aimed at treating neurocognitive disorders. Operating out..

HCA Healthcare, Inc. (HCA): Investor Outlook with Strong Revenue Growth and Analyst Consensus

HCA Healthcare, Inc. (NYSE: HCA) is a prominent name in the healthcare sector, operating an extensive network of medical care facilities across the United States. With a robust market capitalization..

Amgen Inc. (AMGN) Investor Outlook: Strong Revenue Growth and Robust Dividend Yield Highlight Investment Appeal

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and robust dividend yield. As a leading player in the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Close Look at Revenue Growth and Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $15.99 billion, Medpace offers an extensive..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 17.78% Upside Potential in the Biotechnology Sector

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the competitive biotechnology landscape with a compelling 17.78% potential upside, according to analyst ratings. This London-based clinical-stage biopharmaceutical company is making significant..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a Potential 13.53% Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN) is a significant player in the healthcare sector, specializing in medical instruments and supplies. Best known for its Invisalign clear aligners, the company is a..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Potential

Guardant Health, Inc. (NASDAQ: GH), a beacon of innovation in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with its strong revenue growth and potential upside...

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 21.98% Potential Upside Amid Healthcare Innovations

Grifols, S.A. (GRFS), a prominent player within the healthcare sector, stands as a key figure in the global plasma therapeutic space. With its headquarters nestled in Barcelona, Spain, Grifols operates..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 46.6% Upside in Healthcare Tech

Waystar Holding Corp. (WAY), a burgeoning entity in the healthcare sector, is drawing significant attention from investors with its innovative cloud-based software solutions for healthcare payments. Founded in 2017 and..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 19.43% Potential Upside in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its promising portfolio of treatments targeting central nervous system (CNS) disorders. Headquartered in New York, this biopharmaceutical..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Healthcare Growth with a $500 Billion Market Cap

Johnson & Johnson (NYSE: JNJ) stands as a titan in the healthcare industry, commanding a market capitalization of $500.24 billion. As a stalwart in the Drug Manufacturers – General industry,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A 10% Upside Potential in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents an intriguing proposition for investors seeking growth within the biotechnology sector. With a market capitalization of $8.1 billion, this San Diego-based biopharmaceutical company is..

The Cigna Group (CI) Stock Analysis: A 17.51% Upside Potential Amidst Strong Analyst Support

Investors eyeing the healthcare sector should turn their attention to The Cigna Group (NYSE: CI), a stalwart in the healthcare plans industry with a market capitalization of $73.86 billion. With..

West Pharmaceutical Services (WST) Stock Analysis: A Strong Buy with 26% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a titan in the healthcare sector, particularly within the medical instruments and supplies industry, presents an alluring opportunity for investors seeking robust growth potential...

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Riding a 7.66% Potential Upside Wave in Healthcare

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player in the healthcare sector, specializing in health information services. With a substantial market cap of $38.17 billion, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds